Genetic and protein changes of E-cadherin in meningiomas

Akat K, Bleck CK, Lee YM et al (2008) Characterization of a novel type of adherens junction in meningiomas and the derived cell line HBL-52. Cell Tissue Res 331:401–412

Brunner EC, Romeike BF, Jung M et al (2006) Altered expression of beta-catenin/E-cadherin in meningiomas. Histopathology 49:178–187

Ellison DW, Onilude OE, Lindsey JC, United Kingdom Children’s Cancer Study Group Brain Tumour Committee et al (2005) Beta-catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children’s Cancer Study Group Brain Tumour Committee. J Clin Oncol 23:7951–7957

Fogarty MP, Kessler JD, Wechsler-Reya RJ (2005) Morphing into cancer: the role of developmental signaling pathways in brain tumor formation. J Neurobiol 64:458–475

Fuller CE, Perry A (2005) Molecular diagnostics in central nervous system tumors. Adv Anat Pathol 12:180–194

Gordon MD, Nusse R (2006) Wnt signalling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 281:22429–22433

Hall AC, Lucas FR, Salinas PC (2000) Axonal remodeling and synaptic differentiation in the cerebellum is regulated by WNT-7a signaling. Cell 100:525–535

Howng SL, Wu CH, Cheng TS et al (2002) Differential expression of Wnt genes, beta-catenin and E-cadherin in human brain tumors. Cancer Lett 183:95–101

Ionov Y, Peinado MA, Malkhosyan S et al (1993) Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363:558–561

Kleihues P, Louis DN, Scheithauer BW et al (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215–225

Koch A, Waha A, Tonn JC et al (2001) Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors. Int J Cancer 93:445–449

Li F, Chong ZZ, Maiese K (2006) Winding through the WNT pathway during cellular development and demise. Histol Histopathol 21:103–124

Lie DC, Colamarino SA, Song HJ et al (2005) Wnt signalling regulates adult hippocampal neurogenesis. Nature 437:1370–1375

Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109

Nagashima G, Fujimoto T, Suzuki R et al (2006) Dural invasion of meningioma: a histological and immunohistochemical study. Brain Tumor Pathol 23:13–17

Panagopoulos AT, Lancellotti CL, Veiga JC et al (2008) Expression of cell adhesion proteins and proteins related to angiogenesis and fatty acid metabolism in benign, atypical, and anaplastic meningiomas. J Neurooncol 89:73–87

Patapoutian A, Reichardt LF (2000) Roles of wnt proteins in neural development maintenance. Curr Opin Neurobiol 10:392–399

Pećina-Šlaus N (2003) Tumor suppressor gene E-cadherin and its role in normal and malignant cells. Cancer Cell Int E3:17. http://www.cancerci.com/content/3/1/17

Pećina-Šlaus N, Gall-Trošelj K, Kapitanović S et al (2002) Novel alleles of the D16S752 polymorphic genetic marker linked to E-cadherin gene: a potential population marker. Coll Antropol 26:85–88

Pećina-Šlaus N, Nikuševa Martić T, Tomas D et al (2008) Meningiomas exhibit loss of heterozygosity of the APC gene. J Neurooncol 87:63–70

Perry A, Gutmann DH, Reifenberger G (2004) Molecular pathogenesis of meningiomas. J Neurooncol 70:183–202

Polakis P (2007) The many ways of Wnt in cancer. Curr Opin Genet Dev 17:45–51

Riemenschneider MJ, Perry A, Reifenberger G (2006) Histological classification and molecular genetics of meningiomas. Lancet Neurol 5:1045–1054

Schwechheimer K, Zhou L, Birchmeier W (1998) E-cadherin in human brain tumours: loss of immunoreactivity in malignant meningiomas. Virchows Arch 432:163–167

Shimamura K, Takeichi M (1992) Local and transient expression of E-cadherin involved in mouse embryonic brain morphogenesis. Development 116:1011–1019

Utsuki S, Oka H, Sato Y et al (2005) Invasive meningioma is associated with a low expression of E-cadherin and beta-catenin. Clin Neuropathol 24:8–12

Weber RG, Bostrom J, Wolter M et al (1997) Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci USA 94:14719–14724

Wrobel G, Roerig P, Kokocinski F et al (2005) Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identified novel genes associated with meningioma progression. Int J Cancer 114:249–256

Yu X, Malenka RC (2003) Beta-catenin is critical for dendritic morphogenesis. Nat Neurosci 6:1169–1177